Trial Profile
IMRT With Concurrent Chemotherapy and Cetuximab Against Locoregionally Advanced NPC: a Phase 1 Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Aug 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Nedaplatin; Paclitaxel
- Indications Nasopharyngeal cancer
- Focus Adverse reactions
- 29 Nov 2012 New trial record